Evidence map›Paper›PMID 27352632›Full record

ReviewDrug discovery today2016

Physiologically relevant human tissue models for infectious diseases.

Melody Mills, Mary K Estes

Abstract readReview
In one paragraph

Review in Drug discovery today, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. 3D human epithelial models: a promising platform for studyingFrontiers in cellular and infection microbiology · 2025
    Article
  4. Article
  5. Model systems to studyFrontiers in cellular and infection microbiology · 2025
    Review
  6. AnJournal of virology · 2024
    Article
  7. Review
  8. Article
  9. Tissue Models forFrontiers in cellular and infection microbiology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Engineered Human Gastrointestinal Cultures to Study the Microbiome and Infectious Diseases.Cellular and molecular gastroenterology and hepatology · 2018
    Review
  15. Article
  16. Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2018
    Review
  17. Review
  18. Gastrointestinal microphysiological systems.Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Melody MillsDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: millsm@niaid.nih.gov.
Mary K EstesMolecular Virology and Microbiology and Medicine-GI, Baylor College of Medicine, Houston, TX, USA.

Funding

X-ray Crystallographic Studies on CalicivirusesP01AI057788 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ATMAR, ROBERT L., ESTES, MARY KOLB · 2004 to 2024
$34.4M
Novel Platforms for Human Intestinal Enteroids: Matrix, Mechanics, and TopographyU19AI116497 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI PIEDRA, PEDRO A · 2015 to 2025
$13.2M
Regulation of Rotavirus ReplicationR01AI080656 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Sue Ellen Crawford, Mary Kolb Estes · 2009 to 2026
$7.9M
Intramural NIH HHS Z99 AI999999NIAID NIH HHS P01 AI057788NIAID NIH HHS R01 AI080656NIAID NIH HHS U19 AI116497
6 · The paper itself

Abstract

Limitations of animal infection models have engendered longstanding obstacles in basic science and translational research. Lack of suitable animal models, the need for better predictors of human immune responses and pathogens that grow poorly or not at all outside the human host impact our ability to study infectious agents that cause human disease, generation of essential tools for genetic manipulation of microbial pathogens and development of vaccines, therapeutics and host-targeted immunotherapies. The advent of conceptual and methodological advances in tissue engineering along with collaborative efforts between the bioengineering and infectious diseases scientific communities hold great promise to overcome these significant barriers.

Indexed as

Communicable DiseasesModels, BiologicalTissue EngineeringAnimalsHumans

Identifiers

PMID27352632
PMCPMC5365153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.